Dr Julian Saadi Ltd 16072810 doctor false 11 November 2024 16072810 2024-11-11 2025-12-31 16072810 2024-11-10 16072810 2025-12-31 16072810 frs102-bus:FRS102 2024-11-11 2025-12-31 16072810 frs102-bus:PrivateLimitedCompanyLtd 2024-11-11 2025-12-31 16072810 frs102-bus:FullAccounts 2024-11-11 2025-12-31 16072810 frs102-bus:AuditExemptWithAccountantsReport 2024-11-11 2025-12-31 16072810 frs102-core:CurrentFinancialInstruments 2025-12-31 16072810 frs102-core:ShareCapital 2025-12-31 16072810 frs102-core:RetainedEarningsAccumulatedLosses 2025-12-31 16072810 frs102-bus:Director1 2024-11-11 2025-12-31 16072810 frs102-bus:OrdinaryShareClass1 2025-12-31 16072810 frs102-bus:OrdinaryShareClass1 2024-11-11 2025-12-31 xbrli:pure iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares

| Registered number
| 16072810

| Dr Julian Saadi Ltd |
| Unaudited Accounts |
| for the period |
| 11 November 2024 to 31 December 2025 |

Dr Julian Saadi Ltd Balance Sheet as at 31 December 2025
| Notes |  | 2025 £
--- | --- | --- | ---
Current assets |  |  |
Cash at bank and in hand |  | 15,838 |
|  | 15,838 |
Creditors: amounts falling due within one year | 3 | (4,009) |
Net current assets / (liabilities) |  |  | 11,829
Total assets less current liabilities |  |  | 11,829
Provisions for liabilities |  |  | (0)
Total net assets (liabilities) |  |  | 11,829
Capital and reserves |  |  |
Called up share capital | 4 |  | 1
Profit and loss account |  |  | 11,828
Shareholders' funds |  |  | 11,829

Dr Julian Saadi Ltd
Balance Sheet
as at 31 December 2025

These accounts have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

The directors have not delivered a copy of the company's Profit and Loss account as permitted by s444(5A) of the Companies Act 2006.

For the period ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Signed on behalf of the board of directors

...............................

Dr J Saadi

Director

Approved by the board on 15 January 2026

Company Number: 16072810 (a Private Company Limited by Shares registered in England and Wales)

Registered Office:

2e Vale Road
London
E7 8BJ
England

Dr Julian Saadi Ltd
Notes to the Accounts
for the period 11 November 2024 to 31 December 2025

1. | Accounting policies
--- | ---
| Basis of preparation of financial statements These financial statements have been prepared under the historic cost convention in accordance with the accounting policies set out below and with section 1A of FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland, and the Companies Act 2006. The presentation currency is sterling.

| Going concern basis
--- | ---
| The accounts have been prepared on the assumption that the company is able to carry on business as a going concern for the foreseeable future.

| Revenue recognition
--- | ---
| Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances.

| Financial instruments
--- | ---
| Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares that are measured at fair value. Derivative financial instruments are initially recorded at cost and thereafter at fair value. All changes in fair value are recognised in the profit or loss account in the period in which they occurred.

2. | Employees
--- | ---
|  | 2025
| Average number of employees during the period | 0

3. | Creditors: amounts falling due within one year
--- | ---
|  | 2025
|  | £
| Taxation & social security | 2,775
| Other creditors | 1,234
|  | 4,009

4. | Share capital
--- | ---
|  | 2025
|  | £
| Allotted, called up and fully paid: |
| 1 Ordinary shares of £1.00 each | 1
|  | 1
| During the period 1 Ordinary shares were issued. The aggregate nominal value of these shares was £1 and the consideration received was £1.